INVESTOR ALERT: Goldberg Law PC Announces an Investigation of AngioDynamics, Inc.

Goldberg Law PC, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of AngioDynamics, Inc. ("AngioDynamics" or the "Company") ANGO.

If you purchased or otherwise acquired AngioDynamics shares, and would like more information about the investigation, we encourage you to contact Michael Goldberg or Brian Schall, of Goldberg Law PC, 1999 Avenue of the Stars, Suite 1100, Los Angeles, CA 90067, at 800-977-7401, to discuss your rights without cost to you.

You can also reach us through the firm's website at http://www.Goldberglawpc.com, or by email at info@goldberglawpc.com.

The investigation focuses on whether AngioDynamics and certain of its officers and/or directors violated federal securities laws. On July 17, 2017, the Company announced that its auditor discovered that a material weakness existed in its internal control over financial reporting as of May 31, 2016 because AngioDynamics did not design and maintain effective internal controls over the accounting for the annual goodwill impairment test. The Company lacked effective controls to review in sufficient detail the cash flow projections and significant valuation model assumptions used in the goodwill impairment test as of December 31, 2015. Following this news, AngioDynamics' stock price dropped.

If you have any questions concerning your legal rights, please immediately contact Goldberg Law PC at 800-977-7401, or visit our website at http://www.Goldberglawpc.com, or email us at info@goldberglawpc.com.

Goldberg Law PC represents investors around the world, and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170724006306/en/